The estimated Net Worth of Matthew Campobasso is at least $460 Thousand dollars as of 18 June 2024. Matthew Campobasso owns over 1,651 units of Enfusion stock worth over $437,123 and over the last few years Matthew sold ENFN stock worth over $23,203.
Matthew has made over 3 trades of the Enfusion stock since 2024, according to the Form 4 filled with the SEC. Most recently Matthew sold 1,651 units of ENFN stock worth $13,489 on 18 June 2024.
The largest trade Matthew's ever made was selling 1,651 units of Enfusion stock on 18 June 2024 worth over $13,489. On average, Matthew trades about 681 units every 40 days since 2024. As of 18 June 2024 Matthew still owns at least 54,301 units of Enfusion stock.
You can see the complete history of Matthew Campobasso stock trades at the bottom of the page.
Matthew's mailing address filed with the SEC is C/O ENFUSION, INC., 125 SOUTH CLARK STREET, SUITE 750, CHICAGO, IL, 60603.
Over the last 3 years, insiders at Enfusion have traded over $144,301,080 worth of Enfusion stock and bought 2,523,188 units worth $42,894,196 . The most active insiders traders include Investment Management, Ltd...., Bradford Eftv Iv, L.P. Bern..., and Tarek Lra Ventures, Llc Ham.... On average, Enfusion executives and independent directors trade stock every 22 days with the average trade being worth of $2,488,344. The most recent stock trade was executed by Valeria Gutowski on 18 June 2024, trading 1,258 units of ENFN stock currently worth $10,278.
Enfusion executives and other stock owners filed with the SEC include: